Latest Insight Investors 10 predictions for 2021 in cannabis We believe that 2021 is shaping up to be the most significant year yet for the global cannabis sector.
Investors Revisiting my 2019 cannabis industry predictions How Canopy Rivers' President and CEO Narbé Alexandrian's predictions and expectations for the cannabis industry fared against the changes experienced in 2019.
Cannabis Entrepreneurship Tech venture capital is keeping a close watch on cannabis – here are four reasons why With serial entrepreneurs entering the space, an increase in funding year-over-year, and tech venture capital funds starting to invest in cannabis deals, the long-term opportunity for innovation and growth in the cannabis industry looks promising.
Investors Quick Take: Understanding the House Judiciary Committee’s Passage of the MORE Act The MORE Act's passage represents the first time a legislative body of Congress has ever debated and voted on the specific mechanics of how cannabis could be legalized on the federal level.
Investors Infographic: Cannabis Venture Capital Highlights from July-October 2019 Examine data trends at the intersection of venture capital and cannabis between July and October 2019.
Investors Investment criteria Canopy Rivers uses to evaluate cannabis companies Learn about five key indicators that the Canopy Rivers team uses to evaluate companies. This post also contains a helpful infographic highlighting our investment criteria.
Investors How to understand RIV Capital’s financials An infographic that provides clarity in how RIV Capital classifies investments and how that translates in financial statements.
Investors Canopy Rivers' Growth Plan Learn more about how we plan to capitalize on cannabis’ disruptive nature by being life-cycle investors, targeting the deployment of capital across multiple stages of a company’s life.
Cannabis Entrepreneurship Five cannabis podcasts recommended by a venture capitalist Explore our favourite podcasts from the entrepreneurs, investors, and policy makers that shaping the cannabis industry.
Investors Letter to Shareholders (2018-2019) A deeper dive into Canopy Rivers’ strategy and goals, and a look back at where we succeeded and where we need to improve as we continue to build a transformational and enduring business.
Investors The Elephant in the Dispensary: Why Cannabis Beverage Isn’t Big Business…Yet The cannabis beverage segment is only in its infancy, predominantly due to a lack of regulatory clarity.
Investors How BioLumic switches on the growing power of ultraviolet light for cannabis producers Behind Canopy Rivers' investment in agtech company BioLumic.
Investors How ZeaKal’s trait technology plans to supercharge hemp growth Behind Canopy Rivers’ Investment of US$10 Million in ZeaKal, Inc.